SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-13-049324
Filing Date
2013-06-14
Accepted
2013-06-14 16:01:29
Documents
3
Effectiveness Date
2013-06-14

Document Format Files

Seq Description Document Type Size
1 S-8 a13-14863_2s8.htm S-8 114336
2 EX-5.1 a13-14863_2ex5d1.htm EX-5.1 8336
3 EX-23.1 a13-14863_2ex23d1.htm EX-23.1 2423
  Complete submission text file 0001104659-13-049324.txt   126267
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-189336 | Film No.: 13914261
SIC: 2835 In Vitro & In Vivo Diagnostic Substances